INMUNE BIO INC. Demutualization by Insurance Entity, Securities Issued, Gross Cash Proceeds
INMUNE BIO INC. (INMB) reported Demutualization by Insurance Entity, Securities Issued, Gross Cash Proceeds of $38.00 million for the 1-month period ending 2021-07-31, per its 10-K filed 2022-03-03.
Discontinued › Notes
us-gaap:DemutualizationByInsuranceEntitySecuritiesIssuedGrossCashProceeds · last filed 2022-03-03
- 2021-07-31: Demutualization by Insurance Entity, Securities Issued, Gross Cash Proceeds 1 month $38.00M.
| Period end | Demutualization by Insurance Entity, Securities Issued, Gross Cash Proceeds 1 month |
|---|---|
| 2021-07-31 | $38.00M 10-K · filed 2022-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B |